Flipper-TR: the fluorescent membrane tension probe is now on sale
Flipper-TR, the most advanced live cell fluorescent membrane tension probe, is now on sale through our exclusive distributor, Spirochrome.
EPFL Spin-off Cellestia Biotech raises CHF 8 million in seed financing
The company can now carry out clinical trials on its new cancer treatment which has shown excellent efficacy in laboratory tests, and the company has filed several patents.
MassChallenge Switzerland 2016: an NCCR developed methodology wins an award!
Our SwissCompanyMaker alumni have some great wins in the MassChallenge 2016 event. Congratulations!
Quartet Medicine enters strategic agreement with Merck
Agreement provides non-dilutive research and development funding to advance novel pain treatments in exchange for exclusive option.
New DNA stain lights up living cells
EPFL scientists have now developed a new DNA stain that can be used to safely image live mammalian cells for days, even under demanding imaging conditions.
The light of fireflies for medical diagnostics
NCCR scientists at EPFL have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
When a single drop of blood brings Swiss innovation forward
Lucentix develops a new biosensor technology allowing patients to measure themselves with just a single drop of blood and get quicker laboratory-quality results.
